Why Onconova Therapeutic's Is Surging Today

Onconova Therapeutics, Inc. ONTX shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and $4 price target.

Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel products to treat cancer.

The company's stock was trading 45.6% higher at $0.89 per share on Tuesday at the time of publication. The stock has a 52-week high of $1.93 and a 52-week low of $0.19.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Penny StocksPrice TargetInitiationAnalyst RatingsMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!